Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health carelonRx Segment — Total Operating Revenue ($M)
Quarterly figures from Elevance Health's filings and investor materials
Latest, Q3 2026
11,599
Period ended Sep 30, 2026
Change on a year earlier
+5.5%
10,997 in Q3 2025
History
30 quarters
Since Q2 2019
Sources
22
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CarelonRx Segment — Total Operating Revenue ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 11,599 | +5.5% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 11,250 | +5.7% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 10,600 | +4.8% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 11,644 | +16.7% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2025 | Sep 30, 2025 | 10,997 | +20.3% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 10,643 | +21.3% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 10,116 | +25.4% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 9,977 | +13.0% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 9,143 | +7.3% | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 8,774 | +3.6% | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 8,067 | +0.5% | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 8,827 | +17.3% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 8,518 | +17.5% | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 8,466 | +19.7% | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 8,024 | +20.1% | 10-Q (2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 7,523 | +10.6% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| Q3 2022 | Sep 30, 2022 | 7,249 | +10.7% | 8-K ER (FY2022Q3, 2022-10-19) ↗ |
| Q2 2022 | Jun 30, 2022 | 7,071 | +13.7% | 8-K ER (FY2022Q2, 2022-07-20) ↗ |
| Q1 2022 | Mar 31, 2022 | 6,683 | +14.0% | 10-Q (2023-04-19) ↗ |
| Q4 2021 | Dec 31, 2021 | 6,801 | +16.0% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 6,549 | +17.3% | 8-K ER (FY2022Q3, 2022-10-19) ↗ |
| Q2 2021 | Jun 30, 2021 | 6,219 | +18.0% | 8-K ER (FY2022Q2, 2022-07-20) ↗ |
| Q1 2021 | Mar 31, 2021 | 5,862 | +12.8% | 8-K ER (FY2021Q1, 2021-04-21) ↗ |
| Q4 2020 | Dec 31, 2020 | 5,863 | +81.4% | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
| Q3 2020 | Sep 30, 2020 | 5,582 | +190.4% | 8-K ER (FY2021Q3, 2021-10-20) ↗ |
| Q2 2020 | Jun 30, 2020 | 5,269 | +2,024.6% | 8-K ER (FY2021Q2, 2021-07-21) ↗ |
| Q1 2020 | Mar 31, 2020 | 5,197 | – | 8-K ER (FY2021Q1, 2021-04-21) ↗ |
| Q4 2019 | Dec 31, 2019 | 3,232 | – | 8-K ER (FY2020Q4, 2021-01-27) ↗ |
| Q3 2019 | Sep 30, 2019 | 1,922 | – | 8-K ER (FY2020Q3, 2020-10-28) ↗ |
| Q2 2019 | Jun 30, 2019 | 248 | – | 8-K ER (FY2020Q2, 2020-07-29) ↗ |
Breakdown
What makes up carelonrx segment — total operating revenue
Cite this data
StockData. (2026). Elevance Health CarelonRx Segment — Total Operating Revenue ($M), quarterly Q2 2019–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg_rev_carelonrx
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.